President Donald Trump announced a deal with the major pharmaceutical company, Pfizer, on Tuesday to bring down the costs of its products in line with the lowest price paid by other developed nations. However, experts that spoke to Newsweek warned that the deal could be more beneficial for Pfizer than it is for Americans. Rena Conti, a professor in the Department of Markets Public Policy and Law at the Questrom School of Business, Boston University, told Newsweek : "Pfizer is the winner in this

Tag-uri: Pfizer Donald Trump